BUNAZOSIN

Bunazosin is an α1‑blocker reducing intraocular pressure in glaucoma. Side effects include eye irritation, headache, and mild systemic hypotension.

SKU: 3faabdcb7f5a Category: Tag:

Product Description


Mechanism of action

Bunazosin is an α₁-adrenergic receptor antagonist that relaxes vascular smooth muscle, reducing peripheral vascular resistance and blood pressure. In ophthalmic use, bunazosin enhances aqueous-humor outflow by relaxing trabecular meshwork smooth muscle.

Benefits and advantages

Used in adrenergic-signalling research, glaucoma-mechanism studies, vascular-tone modelling, smooth-muscle physiology assays and α₁-receptor SAR investigations.

Side effects and risks

Risks include hypotension, dizziness, syncope, fatigue and mild tachycardia. Handle with adrenergic-antagonist precautions.

Datasheet


Molecular Formula

C19H27N5O3

Molecular Weight

373.4 g/mol

CAS Number

80755-51-7

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Bunazosin; 80755-51-7; Bunazosina; Bunazosine; Bunazosinum

IUPAC/Chemical Name

1-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-1,4-diazepan-1-yl]butan-1-one

InChl Key

RHLJLALHBZGAFM-UHFFFAOYSA-N

InChl Code

InChI=1S/C19H27N5O3/c1-4-6-17(25)23-7-5-8-24(10-9-23)19-21-14-12-16(27-3)15(26-2)11-13(14)18(20)22-19/h11-12H,4-10H2,1-3H3,(H2,20,21,22)

References

https://pubchem.ncbi.nlm.nih.gov/compound/2472;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download